Pembrolizumab as adjuvant therapy in non-small-cell lung cancer. Ganguly S, Gogia A. Lancet Oncol 2022;23:e528.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ganguly S, Gogia A. Pembrolizumab as adjuvant therapy in non-small-cell lung cancer. Lancet Oncol 2022;23:e528.
PMID: 36455577